Thomas Yau and colleagues’ CheckMate 9DW trial has yielded unprecedented results, with nivolumab plus ipilimumab reaching an overall response rate of 36%, a median progression-free survival of 9·1 ...
Abstract: Cervical cell classification is fundamental for early cervical cancer detection. Deep convolutional neural networks (CNNs) have made great progress in enhancing the performance of cervical ...
In stunning new time-lapse videos, biological nanoparticles scoot and flit across a starry field of glowing dots. Guided by ...
Understanding, organizing, and validating data directly affects the accuracy of stories. New tools make cleaning accessible ...
The asterisk (*) is the wildcard character that represents any sequence of characters, including when there are no characters ...
CT-P72/ABP-102 poster selected as one of the Top 150 abstracts out of more than 1,300 submissions at SITC 2025 CT-P72/ABP-102 demonstrates potent and selective anti-tumor activity in HER2-high models, ...
The MarketWatch News Department was not involved in the creation of this content. -- Combination with bispecific T-cell engagers amplifies T-cell recruitment and cytotoxic activity against tumor cells ...
Newly released preclinical data to be presented in a poster on November 8, 2025 SOUTH SAN FRANCISCO, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc., (OTC PINK: CERO) (“CERo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback